GENETICALLY-ENGINEERED DRUG RESISTANT T CELLS AND METHODS OF USING THE SAME Application EP-4295914-A2 European Patent Office 27 Dec 2023
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising… Grant US-11717563-B2 United States of America 08 Aug 2023
GENETICALLY-ENGINEERED DRUG RESISTANT T CELLS AND METHODS OF USING THE SAME Application EP-4006146-A1 European Patent Office 01 Jun 2022
Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of… Grant US-11235069-B2 United States of America 01 Feb 2022